Effects of Different Physical Activity Strategies on Disease Activity of IBD Patients

Brief summary (registry, in English)

The goal of this randomized controlled trial is to evaluate the effects of two different exercise programs, Pilates and combined resistance and aerobic training, on physical activity, kinesiophobia, quality of life, and disease-related outcomes in adults with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The main questions it aims to answer are: * Do the two exercise programs improve physical activity levels, reduce kinesiophobia, and improve quality of life in adults with IBD? * Are there differences between Pilates and combined resistance and aerobic training in their effects on participants' health status and disease-related outcomes? Researchers will compare participants assigned to the Pilates group and the combined resistance and aerobic training group with participants in the control group to evaluate the effects of the exercise programs. Participants will be randomly allocated to one of three groups: a Pilates group, a combined resistance and aerobic training group, or a control group. Participants in the exercise groups will follow their assigned exercise program using online instructional videos twice a week for 12 weeks, with each session lasting 20-30 minutes. They will record completed exercise sessions in an exercise diary. All participants will complete questionnaires before and after the intervention to assess physical activity, kinesiophobia, quality of life, depressive symptoms, knowledge of physical activity, and attitudes towards physiotherapists. Relevant demographic and clinical data will also be collected from medical records.

What you commit to

• Study type: Interventional
• Planned participants: 150
• From 1 Nov 2026 to the primary completion date, 1 Jan 2027
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov